Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Elevated International Normalized Ratio (INR) is Associated With an Increased Risk of Intraventricular Hemorrhage in Extremely Preterm Infants

Glover Williams, Alessandra MD*; Odd, David MD*,†; Bates, Sarah MD*; Russell, Geoff CSci; Heep, Axel MD, FRCPCH*,†

Journal of Pediatric Hematology/Oncology: July 2019 - Volume 41 - Issue 5 - p 355–360
doi: 10.1097/MPH.0000000000001509
Original Articles
Buy
SDC

Introduction: The international normalized ratio (INR), a standardized method of reporting the prothrombin time, can be a surrogate marker of the vitamin K-dependent coagulation pathways.

Objective: To evaluate the relationship between INR measurements in the first 48 hours of life and subsequent development of intraventricular hemorrhage (IVH) in extremely preterm infants.

Materials and Methods: A single-center retrospective, observational cohort study of infants born at <28 weeks gestation. The main outcome measure was defined as the degree of IVH seen on cranial ultrasound examinations at day 7 postnatal age.

Results: Of 200 infants, 109 (mean gestational age, 25.2 wk [SD, 1.27]) had coagulation results available. Of 109, 26 developed IVH. Elevated INR was associated with increased risk of a severe IVH (odds ratio [OR] 6.50; 95% confidence interval [CI], 1.65-25.62; P=0.008) adjusted for gestation, birth weight, and sex. INR was significantly associated with severe IVH in infants who did not receive blood products (OR, 64.60; 95% CI, 1.35-3081.25; P=0.035), but not in those who did (OR, 2.93; 95% CI, 0.67-12.71; P=0.151) (Pinteraction=0.086).

Conclusion: An elevated INR in the first 48 hours of life may be useful to identify preterm infants at risk of severe IVH and may guide strategies to prevent the development, or limit the extension, of IVH.

*Southmead Neonatal Intensive Care Unit

School of Clinical Science, University of Bristol

Department of Haematology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK

A.G.W. and D.O. are equal first authors.

The authors declare no conflict of interest.

Reprints: Axel Heep, MD, FRCPCH, School of Clinical Science, University of Bristol, Neonatal Intensive Care Unit, Southmead Hospital, North Bristol NHS Trust, Southmead Road, Bristol, BS10 NB5, UK (e-mail: axel.heep@bristol.ac.uk).

Received March 9, 2018

Accepted April 7, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.